Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Diabetes insipidus: The other diabetes.

Indian journal of endocrinology and metabolism

Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H.
PMID: 26904464
Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273.

Diabetes insipidus (DI) is a hereditary or acquired condition which disrupts normal life of persons with the condition; disruption is due to increased thirst and passing of large volumes of urine, even at night. A systematic search of literature...

Cite
Kalra S, Zargar AH, Jain SM, et al. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016;20(1):9-21doi: 10.4103/2230-8210.172273.
Kalra, S., Zargar, A. H., Jain, S. M., Sethi, B., Chowdhury, S., Singh, A. K., Thomas, N., Unnikrishnan, A. G., Thakkar, P. B., & Malve, H. (2016). Diabetes insipidus: The other diabetes. Indian journal of endocrinology and metabolism, 20(1), 9-21. https://doi.org/10.4103/2230-8210.172273
Kalra, Sanjay, et al. "Diabetes insipidus: The other diabetes." Indian journal of endocrinology and metabolism vol. 20,1 (2016): 9-21. doi: https://doi.org/10.4103/2230-8210.172273
Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273. PMID: 26904464; PMCID: PMC4743391.
Copy Download .nbib Format: NLM
Bioassay of chlorpropamide for possible carcinogenicity.

National Cancer Institute carcinogenesis technical report series

[No authors listed]
PMID: 12844162
Natl Cancer Inst Carcinog Tech Rep Ser. 1978;45:1-103.

A bioassay of chlorpropamide for possible carcinogenicity was conducted by administering the test material in feed to Fischer 344 rats and B6C3F1 mice. Groups of 35 rats and 35 mice of each sex were administered chlorpropamide as follows: rats...

Cite
Bioassay of chlorpropamide for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1978;45:1-103
(1978). Bioassay of chlorpropamide for possible carcinogenicity. National Cancer Institute carcinogenesis technical report series, 451-103.
"Bioassay of chlorpropamide for possible carcinogenicity." National Cancer Institute carcinogenesis technical report series vol. 45 (1978): 1-103.
Bioassay of chlorpropamide for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1978;45:1-103. PMID: 12844162.
Copy Download .nbib Format: NLM
Synthesis of chlorpropamide-N1-(2, 3, 4, 6-tetra-O-acetyl-beta-D-glucuronide) under phase transfer catalyzed condition.

Pakistan journal of pharmaceutical sciences

Ahmad B, Powell JW.
PMID: 16414619
Pak J Pharm Sci. 1988 Jul;1(2):75-8.

Chlorpropamide-N1-peracetyl glucoside was synthesized by a phase transfer catalysed method. The synthetic product was analysed by spectroscopic techniques (NMR and MS).

Cite
Ahmad B, Powell JW. Synthesis of chlorpropamide-N1-(2, 3, 4, 6-tetra-O-acetyl-beta-D-glucuronide) under phase transfer catalyzed condition. Pak J Pharm Sci. 1988;1(2):75-8
Ahmad, B., & Powell, J. W. (1988). Synthesis of chlorpropamide-N1-(2, 3, 4, 6-tetra-O-acetyl-beta-D-glucuronide) under phase transfer catalyzed condition. Pakistan journal of pharmaceutical sciences, 1(2), 75-8.
Ahmad, B, and Powell, J W. "Synthesis of chlorpropamide-N1-(2, 3, 4, 6-tetra-O-acetyl-beta-D-glucuronide) under phase transfer catalyzed condition." Pakistan journal of pharmaceutical sciences vol. 1,2 (1988): 75-8.
Ahmad B, Powell JW. Synthesis of chlorpropamide-N1-(2, 3, 4, 6-tetra-O-acetyl-beta-D-glucuronide) under phase transfer catalyzed condition. Pak J Pharm Sci. 1988 Jul;1(2):75-8. PMID: 16414619.
Copy Download .nbib Format: NLM
Some pharmacological properties of an aqueous extract of securinega virosa roots.

Pharmaceutical biology

Moshi MJ, Kapingu MC, Uiso FC, Mbwambo ZH, Mahunnah RL.
PMID: 21214465
Pharm Biol. 2000;38(3):214-21. doi: 10.1076/1388-0209(200007)3831-SFT214.

An aqueous extract of Securinega virosa is used by traditional healers in Tanga (northeastern Tanzania) as an aphrodisiac and in the treatment of impotence, which is one of the manifestations of diabetes mellitus. An aqueous extract of the roots...

Cite
Moshi MJ, Kapingu MC, Uiso FC, et al. Some pharmacological properties of an aqueous extract of securinega virosa roots. Pharm Biol. 2000;38(3):214-21doi: 10.1076/1388-0209(200007)3831-SFT214.
Moshi, M. J., Kapingu, M. C., Uiso, F. C., Mbwambo, Z. H., & Mahunnah, R. L. (2000). Some pharmacological properties of an aqueous extract of securinega virosa roots. Pharmaceutical biology, 38(3), 214-21. https://doi.org/10.1076/1388-0209(200007)3831-SFT214
Moshi, M J, et al. "Some pharmacological properties of an aqueous extract of securinega virosa roots." Pharmaceutical biology vol. 38,3 (2000): 214-21. doi: https://doi.org/10.1076/1388-0209(200007)3831-SFT214
Moshi MJ, Kapingu MC, Uiso FC, Mbwambo ZH, Mahunnah RL. Some pharmacological properties of an aqueous extract of securinega virosa roots. Pharm Biol. 2000;38(3):214-21. doi: 10.1076/1388-0209(200007)3831-SFT214. PMID: 21214465.
Copy Download .nbib Format: NLM
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease.

ACS pharmacology & translational science

Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S.
PMID: 33615172
ACS Pharmacol Transl Sci. 2021 Jan 06;4(1):193-205. doi: 10.1021/acsptsci.0c00168. eCollection 2021 Feb 12.

Contemporary literature documents extensive research on common causative mechanisms, pathogenic pathways and dual effective remedies for Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM). Tolbutamide (TBM), chlorpropamide (CPM), and glyburide (GLY) are three sulfonylurea antidiabetic drugs of different...

Cite
Baruah P, Das A, Paul D, et al. Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS Pharmacol Transl Sci. 2021;4(1):193-205doi: 10.1021/acsptsci.0c00168.
Baruah, P., Das, A., Paul, D., Chakrabarty, S., Aguan, K., & Mitra, S. (2021). Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS pharmacology & translational science, 4(1), 193-205. https://doi.org/10.1021/acsptsci.0c00168
Baruah, Prayasee, et al. "Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease." ACS pharmacology & translational science vol. 4,1 (2021): 193-205. doi: https://doi.org/10.1021/acsptsci.0c00168
Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S. Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS Pharmacol Transl Sci. 2021 Jan 06;4(1):193-205. doi: 10.1021/acsptsci.0c00168. eCollection 2021 Feb 12. PMID: 33615172; PMCID: PMC7887854.
Copy Download .nbib Format: NLM
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease.

ACS pharmacology & translational science

Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S.
PMID: 33615172
ACS Pharmacol Transl Sci. 2021 Jan 06;4(1):193-205. doi: 10.1021/acsptsci.0c00168. eCollection 2021 Feb 12.

Contemporary literature documents extensive research on common causative mechanisms, pathogenic pathways and dual effective remedies for Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM). Tolbutamide (TBM), chlorpropamide (CPM), and glyburide (GLY) are three sulfonylurea antidiabetic drugs of different...

Cite
Baruah P, Das A, Paul D, et al. Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS Pharmacol Transl Sci. 2021;4(1):193-205doi: 10.1021/acsptsci.0c00168.
Baruah, P., Das, A., Paul, D., Chakrabarty, S., Aguan, K., & Mitra, S. (2021). Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS pharmacology & translational science, 4(1), 193-205. https://doi.org/10.1021/acsptsci.0c00168
Baruah, Prayasee, et al. "Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease." ACS pharmacology & translational science vol. 4,1 (2021): 193-205. doi: https://doi.org/10.1021/acsptsci.0c00168
Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S. Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease. ACS Pharmacol Transl Sci. 2021 Jan 06;4(1):193-205. doi: 10.1021/acsptsci.0c00168. eCollection 2021 Feb 12. PMID: 33615172; PMCID: PMC7887854.
Copy Download .nbib Format: NLM
Chlorpropamide-induced cholestatic liver failure resulting in death.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Kaminski CA, Angueira E.
PMID: 15251538
Endocr Pract. 1996 May-Jun;2(3):191-2. doi: 10.4158/EP.2.3.191.

OBJECTIVE: To describe the first reported case of a death that occurred as a result of chlorpropamide-induced cholestatic liver disease.METHODS: We review the clinical and laboratory details of an 81-year-old man with type II diabetes mellitus, who was hospitalized...

Cite
Kaminski CA, Angueira E. Chlorpropamide-induced cholestatic liver failure resulting in death. Endocr Pract. 1996;2(3):191-2doi: 10.4158/EP.2.3.191.
Kaminski, C. A., & Angueira, E. (1996). Chlorpropamide-induced cholestatic liver failure resulting in death. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2(3), 191-2. https://doi.org/10.4158/EP.2.3.191
Kaminski, C A, and Angueira, E. "Chlorpropamide-induced cholestatic liver failure resulting in death." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 2,3 (1996): 191-2. doi: https://doi.org/10.4158/EP.2.3.191
Kaminski CA, Angueira E. Chlorpropamide-induced cholestatic liver failure resulting in death. Endocr Pract. 1996 May-Jun;2(3):191-2. doi: 10.4158/EP.2.3.191. PMID: 15251538.
Copy Download .nbib Format: NLM
Alkaloidal extract from .

Heliyon

Kyei-Barffour I, Kwarkoh RKB, Arthur OD, Akwetey SA, Acheampong DO, Aboagye B, Brah AS, Amponsah IK, Adokoh CK.
PMID: 34278033
Heliyon. 2021 Jun 30;7(7):e07452. doi: 10.1016/j.heliyon.2021.e07452. eCollection 2021 Jul.

INTRODUCTION: Increase in the prevalence of type-2 diabetes in Sub-Sahara Africa has created the need for robust treatment and management programs. However, an effective diabetes management program requires a high annual budget that most countries in this region cannot...

Cite
Kyei-Barffour I, Kwarkoh RKB, Arthur OD, et al. Alkaloidal extract from . Heliyon. 2021;7(7):e07452doi: 10.1016/j.heliyon.2021.e07452.
Kyei-Barffour, I., Kwarkoh, R. K. B., Arthur, O. D., Akwetey, S. A., Acheampong, D. O., Aboagye, B., Brah, A. S., Amponsah, I. K., & Adokoh, C. K. (2021). Alkaloidal extract from . Heliyon, 7(7), e07452. https://doi.org/10.1016/j.heliyon.2021.e07452
Kyei-Barffour, Isaac, et al. "Alkaloidal extract from ." Heliyon vol. 7,7 (2021): e07452. doi: https://doi.org/10.1016/j.heliyon.2021.e07452
Kyei-Barffour I, Kwarkoh RKB, Arthur OD, Akwetey SA, Acheampong DO, Aboagye B, Brah AS, Amponsah IK, Adokoh CK. Alkaloidal extract from . Heliyon. 2021 Jun 30;7(7):e07452. doi: 10.1016/j.heliyon.2021.e07452. eCollection 2021 Jul. PMID: 34278033; PMCID: PMC8267442.
Copy Download .nbib Format: NLM
The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.

Frontiers in physiology

Kim S, Jo CH, Kim GH.
PMID: 34955900
Front Physiol. 2021 Dec 10;12:797039. doi: 10.3389/fphys.2021.797039. eCollection 2021.

Hyponatremia is frequently encountered in clinical practice and usually induced by renal water retention. Many medications are considered to be among the various causes of hyponatremia, because they either stimulate the release of arginine vasopressin (AVP) or potentiate its...

Cite
Kim S, Jo CH, Kim GH. The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Front Physiol. 2021;12:797039doi: 10.3389/fphys.2021.797039.
Kim, S., Jo, C. H., & Kim, G. H. (2021). The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Frontiers in physiology, 12797039. https://doi.org/10.3389/fphys.2021.797039
Kim, Sua, et al. "The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia." Frontiers in physiology vol. 12 (2021): 797039. doi: https://doi.org/10.3389/fphys.2021.797039
Kim S, Jo CH, Kim GH. The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Front Physiol. 2021 Dec 10;12:797039. doi: 10.3389/fphys.2021.797039. eCollection 2021. PMID: 34955900; PMCID: PMC8703040.
Copy Download .nbib Format: NLM
Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan.

Indian journal of endocrinology and metabolism

Bashir MI, Pathan MF, Raza SA, Ahmad J, Khan AK, Ishtiaq O, Sahay RK, Sheikh A, Zargar AH.
PMID: 22837904
Indian J Endocrinol Metab. 2012 Jul;16(4):503-7. doi: 10.4103/2230-8210.97994.

It is obligatory for all adult Muslims to observe fast during the holy month of Ramadan, but sick individuals including those with diabetes mellitus are exempted from the duty of fasting. Specific medical advice must be provided to individual...

Cite
Bashir MI, Pathan MF, Raza SA, et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012;16(4):503-7doi: 10.4103/2230-8210.97994.
Bashir, M. I., Pathan, M. F., Raza, S. A., Ahmad, J., Khan, A. K., Ishtiaq, O., Sahay, R. K., Sheikh, A., & Zargar, A. H. (2012). Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian journal of endocrinology and metabolism, 16(4), 503-7. https://doi.org/10.4103/2230-8210.97994
Bashir, Mir Iftikhar, et al. "Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan." Indian journal of endocrinology and metabolism vol. 16,4 (2012): 503-7. doi: https://doi.org/10.4103/2230-8210.97994
Bashir MI, Pathan MF, Raza SA, Ahmad J, Khan AK, Ishtiaq O, Sahay RK, Sheikh A, Zargar AH. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012 Jul;16(4):503-7. doi: 10.4103/2230-8210.97994. PMID: 22837904; PMCID: PMC3401744.
Copy Download .nbib Format: NLM
Effect of caesalpina bonducella seeds on blood glucose in rabbits.

Pharmaceutical biology

Moshi MJ, Nagpa V.
PMID: 21214445
Pharm Biol. 2000;38(2):81-6. doi: 10.1076/1388-0209(200004)3821-1FT081.

The seeds of Caesalpinia bonducella (L.) Flem. (Caesalpiniaceae) are sold in shops in Dar es Salaam, Tanzania, for the treatment of diabetes mellitus. A suspension of the powdered seed kernel in 0.5% carboxymethylcellulose (CMC) was tested for ability to...

Cite
Moshi MJ, Nagpa V. Effect of caesalpina bonducella seeds on blood glucose in rabbits. Pharm Biol. 2000;38(2):81-6doi: 10.1076/1388-0209(200004)3821-1FT081.
Moshi, M. J., & Nagpa, V. (2000). Effect of caesalpina bonducella seeds on blood glucose in rabbits. Pharmaceutical biology, 38(2), 81-6. https://doi.org/10.1076/1388-0209(200004)3821-1FT081
Moshi, M J, and Nagpa, V. "Effect of caesalpina bonducella seeds on blood glucose in rabbits." Pharmaceutical biology vol. 38,2 (2000): 81-6. doi: https://doi.org/10.1076/1388-0209(200004)3821-1FT081
Moshi MJ, Nagpa V. Effect of caesalpina bonducella seeds on blood glucose in rabbits. Pharm Biol. 2000;38(2):81-6. doi: 10.1076/1388-0209(200004)3821-1FT081. PMID: 21214445.
Copy Download .nbib Format: NLM
A radioimmunoassay for determination of glibenclamide and other sulfonylureas.

Pharmaceutical research

Heptner W, Badian M, Baudner S, Hellstern C, Irmisch R, Rupp W, Weimer K, Wissmann H.
PMID: 24277331
Pharm Res. 1984 Sep;1(5):215-20. doi: 10.1023/A:1016321313510.

An antiserum was prepared for the determination of glibenclamide and for the estimation of other commercially available sulfonylureas. Rabbits were immunized with a glibenclamide-BSA conjugate. Tritiated glibenclamide was used as the tracer. The assay was performed in the presence...

Cite
Heptner W, Badian M, Baudner S, et al. A radioimmunoassay for determination of glibenclamide and other sulfonylureas. Pharm Res. 1984;1(5):215-20doi: 10.1023/A:1016321313510.
Heptner, W., Badian, M., Baudner, S., Hellstern, C., Irmisch, R., Rupp, W., Weimer, K., & Wissmann, H. (1984). A radioimmunoassay for determination of glibenclamide and other sulfonylureas. Pharmaceutical research, 1(5), 215-20. https://doi.org/10.1023/A:1016321313510
Heptner, W, et al. "A radioimmunoassay for determination of glibenclamide and other sulfonylureas." Pharmaceutical research vol. 1,5 (1984): 215-20. doi: https://doi.org/10.1023/A:1016321313510
Heptner W, Badian M, Baudner S, Hellstern C, Irmisch R, Rupp W, Weimer K, Wissmann H. A radioimmunoassay for determination of glibenclamide and other sulfonylureas. Pharm Res. 1984 Sep;1(5):215-20. doi: 10.1023/A:1016321313510. PMID: 24277331.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries